APS Support UK/X
Aug 7, 2025, 00:59
Hydroxychloroquine in APS: Anti-Inflammatory and Antithrombotic Effects Supported by Recent Evidence
APS Support UK has shared a post on X:
“ NEW REVIEW | Hydroxychloroquine in APS
- HCQ shows anti-inflammatory/thrombotic effects
- Deacreases platelet aggregation, NET formation, complement (C3a/C5a)
- Supports use in OAPS ( higher birth rate in treated vs untreated: 67% vs 57%).”
Read the full article here.
Title: The Role of Hydroxychloroquine in the Management of Rheumatic Disorders: A Comprehensive Review
Authors: Ilker Ates, Hilal Sahin, Lalu Muhammad Irham, Serkan Yilmaz, Sinan Suzen
Stay updated with the latest scientific advances with Hemostasis Today.
-
Apr 8, 2026, 07:32Giulia Simini: Acquired von Willebrand Syndrome and Coagulation Abnormalities in MPN-Associated Thrombocytosis
-
Apr 8, 2026, 07:14Julian Kyoung-Ryul Chun: Join the Discussion at EHRA 2026
-
Apr 8, 2026, 06:41Stephanie Diez de Sollano: Why Ehlers-Danlos Syndrome Deserves More Attention
-
Apr 7, 2026, 19:17Anand Padmanabhan: Persistence and Pathogenicity of Platelet Factor 4 Antibodies in VITT
-
Apr 7, 2026, 19:07Clara Meijs: Great Time Presenting Our Endometriosis Project at the AHA EPI Lifestyle Conference
-
Apr 7, 2026, 18:18Vivek Das: How Obesity, Type 2 Diabetes, and Dyslipidaemia Interact Across Multiple Cardiovascular Conditions
-
Apr 7, 2026, 17:44Augustina Isioma Ikusemoro: Quality Indicators for Red Blood Cells in Transfusion Medicine
-
Apr 7, 2026, 17:35Nikola Grubor: In Situ Pulmonary Arterial Thrombosis Mimicking CTEPH in Eisenmenger
-
Apr 7, 2026, 17:34Pooja Choradia: vWF Breakdown in Aortic Stenosis – Anaemia and Pulmonary Relevance